Tissue kallikrein promotes survival and β‑catenin degradation in SH‑SY5Y cells under nutrient stress conditions via autophagy

Liu,Yanping; Cui,Mei; Lu,Zhengyu; Yang,Qi; Dong,Qiang

doi:10.3892/mmr.2015.4664

Tissue kallikrein promotes survival and β‑catenin degradation in SH‑SY5Y cells under nutrient stress conditions via autophagy

Authors:
- Yanping Liu
- Mei Cui
- Zhengyu Lu
- Qi Yang
- Qiang Dong
View Affiliations

Affiliations: Department of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai 200040, P.R. China, Department of Neurology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, P.R. China
Published online on: December 9, 2015 https://doi.org/10.3892/mmr.2015.4664
Pages: 1389-1394

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies by our group showed that tissue kallikrein (TK) exerts neuroprotective effects during cerebral ischemia. Autophagy is an important adaptive response to cellular stress during nutrient deprivation, and β‑catenin in known to repress autophagy. The present study investigated the possible involvement of autophagy and β‑catenin signaling in the protective effects of TK under nutrient deprivation-induced stress conditions. TK was shown to promote the survival and inhibit the death of SH‑SY5Y cells under serum starvation and enhanced autophagic activity in a concentration-dependent manner, as indicated by augmented light chain (LC)3‑II levels and Beclin‑1 expression. The autophagy inhibitors 3‑methyladenine and NH4Cl abolished the protective effects of TK. Of note, although serum starvation alone and TK treatment increased p62 protein levels and mRNA expression, incubation with the lysosome inhibitor NH4Cl increased the accumulation of LC3‑II and p62 protein, indicating normal autophagic flux. It was also observed that β‑catenin expression was significantly downregulated by TK treatment. TK stimulated the interaction between LC3 and β‑catenin, and NH4Cl abolished the effects of TK on β‑catenin levels in serum-starved cells, suggesting the autophagic degradation of β‑catenin, which may have led to the enhancement of autophagy. In conclusion, the findings of the present study demonstrated that TK promoted cell survival and β‑catenin degradation in serum‑starved SH‑SY5Y cells via increasing autophagy, which indicated the therapeutic potential of TK under nutrient deprivation-associated stress conditions.

View Figures

View References

1	Tanida I: Autophagosome formation and molecular mechanism of autophagy. Antioxid Redox Signal. 14:2201–2214. 2011. View Article : Google Scholar
2	Bhoola KD, Figueroa CD and Worthy K: Bioregulation of kinins: Kallikreins, kininogens and kininases. Pharmacol Rev. 44:1–80. 1992.PubMed/NCBI
3	Su J, Tang Y, Zhou H, Liu L and Dong Q: Tissue kallikrein protects neurons from hypoxia/reoxygenation-induced cell injury through Homer1b/c. Cell Signal. 24:2205–2215. 2012. View Article : Google Scholar : PubMed/NCBI
4	Wang Z, Han X, Cui M, Fang K, Lu Z and Dong Q: Tissue kallikrein protects rat hippocampal CA1 neurons against cerebral ischemia/reperfusion-induced injury through the B2R-Raf-MEK1/2-ERK1/2 pathway. J Neurosci Res. 92:651–657. 2014. View Article : Google Scholar : PubMed/NCBI
5	Tang Y, Shao Y, Su J, Zhou H, Liu L, Ren H and Dong Q: The protein therapy of kallikrein in cerebral ischemic reperfusion injury. Curr Med Chem. 16:4502–4510. 2009. View Article : Google Scholar : PubMed/NCBI
6	Papadakis M, Hadley G, Xilouri M, Hoyte LC, Nagel S, McMenamin MM, Tsaknakis G, Watt SM, Drakesmith CW, Chen R, et al: Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy. Nat Med. 19:351–357. 2013. View Article : Google Scholar : PubMed/NCBI
7	Yuan G, Deng J, Wang T, Zhao C, Xu X, Wang P, Voltz JW, Edin ML, Xiao X, Chao L, et al: Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinaseB and adenosine 5′-monophosphate-activated protein kinase signaling pathways. Endocrinology. 148:2016–2026. 2007. View Article : Google Scholar : PubMed/NCBI
8	Kim JH, Hong SK, Wu PK, Richards AL, Jackson WT and Park JI: Raf/MEK/ERK can regulate cellular levels of LC3B and SQSTM1/p62 at expression levels. Exp Cell Res. 327:340–352. 2014. View Article : Google Scholar : PubMed/NCBI
9	Wang J, Whiteman MW, Lian H, Wang G, Singh A, Huang D and Denmark T: A non-canonical MEK/ERK signaling pathway regulates autophagy via regulating Beclin 1. J Biol Chem. 284:21412–21424. 2009. View Article : Google Scholar : PubMed/NCBI
10	Moon RT: Wnt/beta-catenin pathway. Sci STKE. 2005:2005.PubMed/NCBI
11	Petherick KJ, Williams AC, Lane JD, Ordóñez-Morán P, Huelsken J, Collard TJ, Smartt HJ, Batson J, Malik K, Paraskeva C and Greenhough A: Autolysosomal β-catenin degradation regulates Wnt-autophagy-p62 crosstalk. EMBO J. 32:1903–1916. 2013. View Article : Google Scholar : PubMed/NCBI
12	Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, et al: Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 8:445–544. 2012. View Article : Google Scholar : PubMed/NCBI
13	Waeckel L, Potier L, Richer C, Roussel R, Bouby N and Alhenc-Gelas F: Pathophysiology of genetic deficiency in tissue kallikrein activity in mouse and man. Thromb Haemost. 110:476–483. 2013. View Article : Google Scholar : PubMed/NCBI
14	Chao J, Shen B, Gao L, Xia CF, Bledsoe G and Chao L: Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing. Biol Chem. 391:345–355. 2010. View Article : Google Scholar : PubMed/NCBI
15	Yao YY, Yin H, Shen B, Smith RS Jr, Liu Y, Gao L, Chao L and Chao J: Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway. Cardiovasc Res. 80:354–364. 2008. View Article : Google Scholar : PubMed/NCBI
16	Lu Z, Yang Q, Cui M, Liu Y, Wang T, Zhao H and Dong Q: Tissue kallikrein induces SH-SY5Y cell proliferation via epidermal growth factor receptor and extracellular signal-regulated kinase1/2 pathway. Biochem Biophys Res Commun. 446:25–29. 2014. View Article : Google Scholar : PubMed/NCBI
17	Chong ZZ and Maiese K: Targeting WNT, protein kinase B and mitochondrial membrane integrity to foster cellular survival in the nervous system. Histol Histopathol. 19:495–504. 2004.PubMed/NCBI
18	Heras-Sandoval D, Pérez-Rojas JM, Hernández-Damián J and Pedraza-Chaverri J: The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal. 26:2694–2701. 2014. View Article : Google Scholar : PubMed/NCBI
19	Georgopoulos NT, Kirkwood LA and Southgate J: A novel bidirectional positive-feedback loop between Wnt-β-catenin and EGFR-ERK plays a role in context-specific modulation of epithelial tissue regeneration. J Cell Sci. 127:2967–2982. 2014. View Article : Google Scholar : PubMed/NCBI
20	Wei Y, Zou Z, Becker N, Anderson M, Sumpter R, Xiao G, Kinch L, Koduru P, Christudass CS, Veltri RW, et al: EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance. Cell. 154:1269–1284. 2013. View Article : Google Scholar : PubMed/NCBI
21	Bjørkøy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H and Johansen T: P62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol. 171:603–614. 2005. View Article : Google Scholar : PubMed/NCBI